266 related articles for article (PubMed ID: 29847567)
21. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Aslan G; Tezcan S; Serin MS; Emekdas G
Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
[TBL] [Abstract][Full Text] [Related]
22. High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Choi GE; Lee SM; Yi J; Hwang SH; Kim HH; Lee EY; Cho EH; Kim JH; Kim HJ; Chang CL
J Clin Microbiol; 2010 Nov; 48(11):3893-8. PubMed ID: 20844231
[TBL] [Abstract][Full Text] [Related]
23. Drug resistant
Al Mahrouqi S; Gadalla A; Al Azri S; Al-Hamidhi S; Al-Jardani A; Balkhair A; Al-Fahdi A; Al Balushi L; Al Zadjali S; Al Marhoubi AMN; Babiker HA
PeerJ; 2022; 10():e13645. PubMed ID: 35919400
[TBL] [Abstract][Full Text] [Related]
24. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
25. Molecular Characterization of Mutations in Isoniazid- and Rifampicin-Resistant Mycobacterium tuberculosis Isolated in Thailand.
Rudeeaneksin J; Phetsuksiri B; Nakajima C; Fukushima Y; Suthachai W; Tipkrua N; Suthum K; Jekloh N; Bunchoo S; Srisungngam S; Klayut W; Hamada S; Suzuki Y
Jpn J Infect Dis; 2023 Jan; 76(1):39-45. PubMed ID: 36047179
[TBL] [Abstract][Full Text] [Related]
26. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mboowa G; Namaganda C; Ssengooba W
BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
[TBL] [Abstract][Full Text] [Related]
27. Differences in rpoB, katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDRplus assay.
Alvarez-Uria G; Reddy R
Infect Genet Evol; 2018 Apr; 59():48-50. PubMed ID: 29413885
[TBL] [Abstract][Full Text] [Related]
28. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Sharma S; Madan M; Agrawal C; Asthana AK
Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
[TBL] [Abstract][Full Text] [Related]
29. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
Isakova ZhT
Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas EM
Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
[TBL] [Abstract][Full Text] [Related]
31. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea.
Park YK; Shin S; Ryu S; Cho SN; Koh WJ; Kwon OJ; Shim YS; Lew WJ; Bai GH
J Microbiol Methods; 2005 Nov; 63(2):165-72. PubMed ID: 15893392
[TBL] [Abstract][Full Text] [Related]
32. Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.
Chen X; Kong F; Wang Q; Li C; Zhang J; Gilbert GL
J Clin Microbiol; 2011 Oct; 49(10):3450-7. PubMed ID: 21832014
[TBL] [Abstract][Full Text] [Related]
33. Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among
Haratiasl AA; Hamzelou G; Amini S; Kardan-Yamchi J; Haeili M; Heidari F; Feizabadi MM
J Chemother; 2020 Apr; 32(2):75-82. PubMed ID: 32009582
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
[TBL] [Abstract][Full Text] [Related]
36. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
[TBL] [Abstract][Full Text] [Related]
37. Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.
Havlicek J; Dachsel B; Slickers P; Andres S; Beckert P; Feuerriegel S; Niemann S; Merker M; Labugger I
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29212699
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh.
Rahim Z; Nakajima C; Raqib R; Zaman K; Endtz HP; van der Zanden AG; Suzuki Y
Tuberculosis (Edinb); 2012 Nov; 92(6):529-34. PubMed ID: 22863574
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Ogari CO; Nyamache AK; Nonoh J; Amukoye E
BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
[TBL] [Abstract][Full Text] [Related]
40. Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population.
Prakash R; Gupta R; Katoch VM; Tiwari PK
J Infect Public Health; 2017; 10(5):593-599. PubMed ID: 28245964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
